Reuters logo
a year ago
BRIEF-China Resources Double-Crane Pharmaceutical receives drug clinical trial permission
May 24, 2016 / 6:11 AM / a year ago

BRIEF-China Resources Double-Crane Pharmaceutical receives drug clinical trial permission

May 24 (Reuters) - China Resources Double-Crane Pharmaceutical Co., Ltd.:

* Says it received drug clinical trial permission from State Food and Drug Administration, for ezetimibe tablets

Source text in Chinese: me2.do/GxXF9b8J

Further company Coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below